Panaxynol mitigates chemotherapy-induced intestinal mucositis by improving the colonic microenvironment in murine models
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.06.2026 · 330 (6) · G728-G748
DOI: 10.1152/ajpgi.00035.2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.06.2026. Verfasst von Brooke M Bullard und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States. Hauptthemen laut MEDLINE: Fluorouracil, Mucositis, Colon, Diynes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS), HHS | NIH | National Cancer Institute (NCI).
Themen: Onkologische Pflege
Abstract (Originalsprache)
This study identifies panaxynol, a bioactive compound from American ginseng, as a novel therapeutic candidate for chemotherapy-induced intestinal mucositis. In a murine 5-fluorouracil model, panaxynol attenuated mucosal injury, reduced cytopenia, suppressed proinflammatory immune cells, and altered gut microbial community structure. Importantly, panaxynol exhibited sex-dependent effects, with stronger immunological and microbial modulation in males. These findings highlight panaxynol’s pleiotropic protective actions and underscore the importance of sex as a biological variable in mucositis therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.
- Department of Science, College of Professional Advancement, Mercer University, Atlanta, Georgia, United States.
- Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States.
- Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado, United States.
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States.
- Department of Nutritional Sciences, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States.
ORCID-Profile: Brooke M Bullard, Brandon N VanderVeen, Thomas D Cardaci, Arianna V Bastian, Nathaniel B Willis, Joseph F Pierre, E Angela Murphy
Förderung
- NCI NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- HHS | NIH | National Cancer Institute (NCI)
- NIGMS NIH HHS
- HHS | NIH | National Center for Complementary and Integrative Health (OAM)
- NCCIH NIH HHS
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIDDK NIH HHS
Zitieren
APA
Bullard, B. M., VanderVeen, B. N., Cardaci, T. D., McDonald, S. J., Bastian, A. V., Willis, N. B., Xu, M., Li, J., Pierre, J. F., Hofseth, L. J., Fan, D., & Murphy, E. A. (2026). Panaxynol mitigates chemotherapy-induced intestinal mucositis by improving the colonic microenvironment in murine models. American Journal of Physiology-Gastrointestinal and Liver Physiology, 330(6), G728-G748. https://doi.org/10.1152/ajpgi.00035.2026
Vancouver
Bullard BM, VanderVeen BN, Cardaci TD, McDonald SJ, Bastian AV, Willis NB, et al. Panaxynol mitigates chemotherapy-induced intestinal mucositis by improving the colonic microenvironment in murine models. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2026;330(6):G728-G748. doi:10.1152/ajpgi.00035.2026
BibTeX
@article{Bullard2026,
author = {Bullard, Brooke M and VanderVeen, Brandon N and Cardaci, Thomas D and McDonald, Sierra J and Bastian, Arianna V and Willis, Nathaniel B and Xu, Mingming and Li, Jie and Pierre, Joseph F and Hofseth, Lorne J and Fan, Daping and Murphy, E Angela},
title = {Panaxynol mitigates chemotherapy-induced intestinal mucositis by improving the colonic microenvironment in murine models},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2026},
volume = {330},
number = {6},
pages = {G728--G748},
doi = {10.1152/ajpgi.00035.2026}
}
EUVIMED